• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Economy Socio Economic

Covid vaccine: Scientists raise concern over risk of heart inflammation in young adults

Chidinma Anyalewechi by Chidinma Anyalewechi
October 18, 2021
in Socio Economic
Covid vaccine: Scientists raise concern over risk of heart inflammation in young adults
Share on FacebookShare on TwitterShare on Linkedin

Top scientists are still weighing whether to approve third doses of COVID-19 vaccine for anyone over 12 years as the risks of booster shots causing heart inflammation continues to be a source of concern.

This comment was made by a voting member of the Food and Drug Administration’s advisory panel, Dr. Ofer Levy, according to CBNC.

Dr. Levy, who is also the director of the Precision Vaccines Program at Boston Children’s Hospital, made the comment hours after second shots to all recipients of Johnson & Johnson’s single-dose Covid vaccine over 18 years old was unanimously recommended by the FDA’s Vaccines and Related Biological Products Advisory Committee.

MoreStories

Tinubunomics Not Working: SME’s groan over rising cost of doing business

September 21, 2025
IMF Spring Meetings: Edun, Cardoso declare Nigeria’s reforms are winning global endorsement

IMF Spring Meetings: Edun, Cardoso declare Nigeria’s reforms are winning global endorsement

April 26, 2025

What this means

Although, boosters from Moderna and Pfizer for all seniors and other high-risk groups has previously been recommended, some committee members have withheld their support for the authorization of third mRNA doses for people aged 12 and above due to the risk of two rare heart inflammation conditions, myocarditis and pericarditis as warned by scientists.

Dr. Levy said, “As we go into younger and younger age groups, they’re less and less at personal risk of severe Covid, and on the other hand, somewhat more at risk of this inflammatory heart condition with the mRNA vaccine. So, it’s a risk benefit analysis, and that’s why you’re seeing that deliberation.”

The Centers for Disease Control and Prevention has said the heart inflammation condition called myocarditis has been found mostly in male adolescents and young adults who received the Pfizer or Moderna vaccine and these complications arise within days of vaccination and usually happens after the second dose, however, it subsides when treated with medicine.

Studies also show that unlike the vaccines from Pfizer and Moderna, the Johnson & Johnson’s Covid shot is not associated with a risk for heart inflammation and over 15 million Americans have received the primary vaccine dose from J&J.

Tags: Covid vaccineDr. Ofer Levy.FDAModernaPfizerU.S. Food and Drug Administration
Chidinma Anyalewechi

Chidinma Anyalewechi

For further inquiries about this article, contact: Email: chidinma.anyalewechi@nairametrics.com LinkedIn: linkedin.com/in/chidinma-anyalewechi-a323ab173/

Next Post
Piggyvest discounts claims they lost N2 billion to alleged fraud by Imagine Global Solution Limited

Piggyvest discounts claims they lost N2 billion to alleged fraud by Imagine Global Solution Limited

Comments 1

  1. C. I. Albert says:
    October 18, 2021 at 11:01 am

    The saturated outcome of this hasty innovation would come in about 3-5yrs time. No one is monitoring death by hunger; No one is monitoring death by Malaria and no one is ensuring Nobody goes to bed hungry but then, the Vaccine MUST be taken, the more they enforce it, the more the skeptism.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast

nairametrics




DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics